31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cell Cycle Regulation During Viral Infection

      chapter-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To replicate their genomes in cells and generate new progeny, viruses typically require factors provided by the cells that they have infected. Subversion of the cellular machinery that controls replication of the infected host cell is a common activity of many viruses. Viruses employ different strategies to deregulate cell cycle checkpoint controls and modulate cell proliferation pathways. A number of DNA and RNA viruses encode proteins that target critical cell cycle regulators to achieve cellular conditions that are beneficial for viral replication. Many DNA viruses induce quiescent cells to enter the cell cycle; this is thought to increase pools of deoxynucleotides and thus, facilitate viral replication. In contrast, some viruses can arrest cells in a particular phase of the cell cycle that is favorable for replication of the specific virus. Cell cycle arrest may inhibit early cell death of infected cells, allow the cells to evade immune defenses, or help promote virus assembly. Although beneficial for the viral life cycle, virus-mediated alterations in normal cell cycle control mechanisms could have detrimental effects on cellular physiology and may ultimately contribute to pathologies associated with the viral infection, including cell transformation and cancer progression and maintenance. In this chapter, we summarize various strategies employed by DNA and RNA viruses to modulate the replication cycle of the virus-infected cell. When known, we describe how these virus-associated effects influence replication of the virus and contribute to diseases associated with infection by that specific virus.

          Related collections

          Most cited references314

          • Record: found
          • Abstract: found
          • Article: not found

          Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

          P Rota (2003)
          In March 2003, a novel coronavirus (SARS-CoV) was discovered in association with cases of severe acute respiratory syndrome (SARS). The sequence of the complete genome of SARS-CoV was determined, and the initial characterization of the viral genome is presented in this report. The genome of SARS-CoV is 29,727 nucleotides in length and has 11 open reading frames, and its genome organization is similar to that of other coronaviruses. Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closely related to any of the previously characterized coronaviruses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

            In efforts to inform public health decision makers, the Global Burden of Diseases, Injuries, and Risk Factors 2010 (GBD2010) Study aims to estimate the burden of disease using available parameters. This study was conducted to collect and analyze available prevalence data to be used for estimating the hepatitis C virus (HCV) burden of disease. In this systematic review, antibody to HCV (anti-HCV) seroprevalence data from 232 articles were pooled to estimate age-specific seroprevalence curves in 1990 and 2005, and to produce age-standardized prevalence estimates for each of 21 GBD regions using a model-based meta-analysis. This review finds that globally the prevalence and number of people with anti-HCV has increased from 2.3% (95% uncertainty interval [UI]: 2.1%-2.5%) to 2.8% (95% UI: 2.6%-3.1%) and >122 million to >185 million between 1990 and 2005. Central and East Asia and North Africa/Middle East are estimated to have high prevalence (>3.5%); South and Southeast Asia, sub-Saharan Africa, Andean, Central, and Southern Latin America, Caribbean, Oceania, Australasia, and Central, Eastern, and Western Europe have moderate prevalence (1.5%-3.5%); whereas Asia Pacific, Tropical Latin America, and North America have low prevalence (<1.5%). The high prevalence of global HCV infection necessitates renewed efforts in primary prevention, including vaccine development, as well as new approaches to secondary and tertiary prevention to reduce the burden of chronic liver disease and to improve survival for those who already have evidence of liver disease. Copyright © 2012 American Association for the Study of Liver Diseases.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              CDK inhibitors: positive and negative regulators of G1-phase progression.

                Bookmark

                Author and article information

                Contributors
                +12157624825 , +12157624452 , enoguchi@drexelmed.edu
                +1214-762-4825 , +1215-762-4452 , mcg59@drexel.edu
                michael.bouchard@drexelmed.edu
                Journal
                978-1-4939-0888-2
                10.1007/978-1-4939-0888-2
                Cell Cycle Control
                Cell Cycle Control
                Mechanisms and Protocols
                978-1-4939-0887-5
                978-1-4939-0888-2
                27 March 2014
                2014
                : 1170
                : 165-227
                Affiliations
                [2 ]GRID grid.166341.7, ISNI 0000000121813113, Department of Biochemistry and Molecular Biology, , Drexel University College of Medicine, ; Philadelphia, Pennsylvania USA
                [3 ]GRID grid.166341.7, ISNI 0000000121813113, Dept of Biochemistry & Molecular Biology, , Drexel University College of Medicine, ; Philadelphia, USA
                GRID grid.166341.7, ISNI 0000000121813113, Department of Biochemistry and Molecular Biology, , Drexel University College of Medicine, ; 245 N 15th Street, MS 497, Philadelphia, PA 19102 USA
                Article
                10
                10.1007/978-1-4939-0888-2_10
                7122065
                24906315
                5a40d3fd-0c37-4501-8ed7-5b1f9d2918db
                © Springer Science+Business Media New York 2014

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                Categories
                Article
                Custom metadata
                © Springer Science+Business Media New York 2014

                cell cycle,regulation,dna and rna viruses,consequences
                cell cycle, regulation, dna and rna viruses, consequences

                Comments

                Comment on this article